Back to Search Results

A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (B-FAST:

LOCALLY ADVANCED/ METASTATIC - First Line

Condition:	Intervention:	Phase:
Lung Cancer		II

Status:	Open (Show results)
Volunteers Required:	Yes
Published Date:	20 October 2020

Term of Use/Disclaimer

All information provided within this web and mobile application is intended for general information and is provided on the understanding that no surgical and medical advice or recommendation is being rendered. Please do not disregard the professional advice of your physician.